Skip to content

Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases

Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05797051
Enrollment
80
Registered
2023-04-04
Start date
2023-05-30
Completion date
2023-09-20
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Nephropathies, Glomerulonephritis, IGA, Glomerulonephritis, Membranous, Hyperspectral Imaging, Nephrosis, Lipoid

Brief summary

Morning urine samples of patients with IgA nephropathy, idiopathic membranous nephropathy, diabetic nephropathy, and minimal degenerative nephropathy confirmed by renal needle biopsy in our hospital from November 2020 to January 2022 were collected. By scanning the morning urine samples of corresponding patients with microhyperspectral imager, machine learning and deep learning were used to classify microhyperspectral images, and the classification accuracy was greater than 85%. Thus, hyperspectral imaging technology could be used as a non-invasive diagnostic means to assist the diagnosis of glomerular diseases.

Interventions

Microscopic hyperspectral imaging system

Sponsors

Qianfoshan Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Over 18 years old; * Patients with IgA nephropathy, idiopathic membranous nephropathy, diabetic nephropathy, minimal change nephropathy confirmed by renal biopsy; * Had not received hormone and/or immunosuppressive therapy before renal biopsy; * Complete clinical data, all signed the Admission Certificate of Qianfoshan Hospital of Shandong Province, and agreed to use relevant medical information, biological specimen examination and examination results for scientific research.

Exclusion criteria

* There are factors causing secondary membranous nephropathy, such as immune diseases (systemic lupus erythematosus), tumors/infections (viral hepatitis), drugs or poisons, etc.; * Severe infection: fever, cough and expectoration, sore throat, abdominal pain, diarrhea, carbuncle and furuncle and other clinical manifestations of skin and soft tissue infection, blood routine white blood cell count beyond the normal range (10×109/L); * Severe cardiovascular disease: including chronic heart failure grade 3 or above and various arrhythmias; * Infectious diseases: active hepatitis, AIDS, syphilis, etc. ; * Tumor evidence: it has been found that there is a certain tumor or clinical manifestations, tumor markers, etc., suggesting the possibility of tumor.

Design outcomes

Primary

MeasureTime frameDescription
Microhyperspectral image of urine specimen2023.4-2023.10Microhyperspectral images of urine samples from patients with four different glomerular diseases before treatment

Contacts

Primary ContactWang Zongsong
wzsong3@163.com18660190175

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026